A detailed history of Freestone Grove Partners LP transactions in Cabot Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 4,305 shares of CBT stock, worth $380,303. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,305
Holding current value
$380,303
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$90.64 - $117.0 $390,205 - $503,685
4,305 New
4,305 $393 Million

Others Institutions Holding CBT

About CABOT CORP


  • Ticker CBT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 56,299,200
  • Market Cap $4.97B
  • Description
  • Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such...
More about CBT
Track This Portfolio

Track Freestone Grove Partners LP Portfolio

Follow Freestone Grove Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Grove Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Grove Partners LP with notifications on news.